Cargando…

Trial participants' rights after authorisation of COVID-19 vaccines

Detalles Bibliográficos
Autores principales: Dal-Ré, Rafael, Orenstein, Walter, Caplan, Arthur L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816575/
https://www.ncbi.nlm.nih.gov/pubmed/33476582
http://dx.doi.org/10.1016/S2213-2600(21)00044-8
_version_ 1783638470861783040
author Dal-Ré, Rafael
Orenstein, Walter
Caplan, Arthur L
author_facet Dal-Ré, Rafael
Orenstein, Walter
Caplan, Arthur L
author_sort Dal-Ré, Rafael
collection PubMed
description
format Online
Article
Text
id pubmed-7816575
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78165752021-01-21 Trial participants' rights after authorisation of COVID-19 vaccines Dal-Ré, Rafael Orenstein, Walter Caplan, Arthur L Lancet Respir Med Correspondence Elsevier Ltd. 2021-04 2021-01-18 /pmc/articles/PMC7816575/ /pubmed/33476582 http://dx.doi.org/10.1016/S2213-2600(21)00044-8 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Dal-Ré, Rafael
Orenstein, Walter
Caplan, Arthur L
Trial participants' rights after authorisation of COVID-19 vaccines
title Trial participants' rights after authorisation of COVID-19 vaccines
title_full Trial participants' rights after authorisation of COVID-19 vaccines
title_fullStr Trial participants' rights after authorisation of COVID-19 vaccines
title_full_unstemmed Trial participants' rights after authorisation of COVID-19 vaccines
title_short Trial participants' rights after authorisation of COVID-19 vaccines
title_sort trial participants' rights after authorisation of covid-19 vaccines
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816575/
https://www.ncbi.nlm.nih.gov/pubmed/33476582
http://dx.doi.org/10.1016/S2213-2600(21)00044-8
work_keys_str_mv AT dalrerafael trialparticipantsrightsafterauthorisationofcovid19vaccines
AT orensteinwalter trialparticipantsrightsafterauthorisationofcovid19vaccines
AT caplanarthurl trialparticipantsrightsafterauthorisationofcovid19vaccines